Matches in Wikidata for { <http://www.wikidata.org/entity/Q94429414> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94429414 description "article scientifique publié en 2019" @default.
- Q94429414 description "wetenschappelijk artikel" @default.
- Q94429414 description "наукова стаття" @default.
- Q94429414 name "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 name "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 type Item @default.
- Q94429414 label "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 label "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 prefLabel "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 prefLabel "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 P1433 Q94429414-B91EE96F-BCB5-424A-A9C8-A52F0AAE675B @default.
- Q94429414 P1476 Q94429414-BBB599BF-72FC-41B7-B264-BC30358C309E @default.
- Q94429414 P2093 Q94429414-1020EF62-ED3D-4E00-ABC9-7E030AB39BF8 @default.
- Q94429414 P2093 Q94429414-38322B90-5B23-43CE-A702-09EA73002DE3 @default.
- Q94429414 P2093 Q94429414-739C3639-111B-4B14-9BF3-19ABEEB22806 @default.
- Q94429414 P2093 Q94429414-A006609F-6DCE-4E6A-AE81-19C11037EC35 @default.
- Q94429414 P275 Q94429414-0e5138e3-7474-457b-a389-c417ea26e231 @default.
- Q94429414 P31 Q94429414-2B40F753-D5D2-49B1-A454-6BAC3A3F4C80 @default.
- Q94429414 P356 Q94429414-9EE94863-0F75-41D2-8453-A3332B208EB5 @default.
- Q94429414 P407 Q94429414-8522C127-BA2D-4BB9-873B-E6C21F6C310A @default.
- Q94429414 P433 Q94429414-C97240F1-1A97-4CBF-A7BF-4E9CE0D88F7F @default.
- Q94429414 P478 Q94429414-DFFDAF9B-1CE6-42CC-8AEB-54F7D792CBD8 @default.
- Q94429414 P577 Q94429414-F6E83163-2B51-4EB8-A358-1862762F2740 @default.
- Q94429414 P6216 Q94429414-8761915d-aaaa-481d-94d4-b64dc3146b6d @default.
- Q94429414 P921 Q94429414-0785FB03-E0CB-4EA1-AB7E-18FA088AEA2C @default.
- Q94429414 P921 Q94429414-F6F4B4F1-85E2-4669-AC29-E18C84AF5D42 @default.
- Q94429414 P932 Q94429414-5E01A206-BE41-4848-9313-52B8DCA3EB59 @default.
- Q94429414 P356 JS.2019-SUN-357 @default.
- Q94429414 P1433 Q50817780 @default.
- Q94429414 P1476 "SUN-357 Trial in Progress: A Multicenter, Dose-titration, Open-Label Phase 2b Study of Nevanimibe Hydrochloride, a Novel ACAT1 Inhibitor, for the Treatment of Classic Congenital Adrenal Hyperplasia" @default.
- Q94429414 P2093 "M. Marian Ijzerman" @default.
- Q94429414 P2093 "Marianne Plaunt" @default.
- Q94429414 P2093 "Pharis Mohideen" @default.
- Q94429414 P2093 "Vivian Lin" @default.
- Q94429414 P275 Q24082749 @default.
- Q94429414 P31 Q13442814 @default.
- Q94429414 P356 "10.1210/JS.2019-SUN-357" @default.
- Q94429414 P407 Q1860 @default.
- Q94429414 P433 "Suppl 1" @default.
- Q94429414 P478 "3" @default.
- Q94429414 P577 "2019-04-30T00:00:00Z" @default.
- Q94429414 P6216 Q50423863 @default.
- Q94429414 P921 Q366868 @default.
- Q94429414 P921 Q6934595 @default.
- Q94429414 P932 "6552740" @default.